KAREN J WILSON
CIK 1267490 · SVP, Finance & PAO · last filed 2026-05-26
KAREN J WILSON is a SVP, Finance & PAO who has filed 57 SEC Form 4 insider transactions across 7 companies since 2009. The most recent filing shows the insider bought $37.0K of SER on May 26, 2026. Across all open-market trades the lifetime net is −$11.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.26M
7
57
-$11.48M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SER | Director | 10,000 | $1.84 | $18.4K | $37.0K | 3 | 2026-05-26 |
| LAVA Therapeutics NV (LVTX) Delisted | Director | 0 | $1.74 | $0 | $0 | 2 | 2025-11-17 |
| ELTX | Director | — | $14.85 | — | $0 | 3 | 2025-05-20 |
| Elicio Therapeutics, Inc. (ANGN) Delisted | Director | 18,718 | $10.00 | $187.2K | $0 | 3 | 2022-06-13 |
| Vaxart, Inc. (VXRT) Delisted | Director | — | $0.32 | — | $0 | 2 | 2021-06-17 |
| JAZZ | SVP, Finance & PAO | 18,385 | $230.56 | $4.24M | -$11.52M | 43 | 2019-03-07 |
| PDL BIOPHARMA, INC. (PDLI) Delisted | VP of Finance & PAO | 10,494 | — | — | $0 | 1 | 2009-05-11 |
Recent Filings
57 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-26 | SER | Buy (P) | +20,000 | $37.0K | EDGAR |
| 2025-11-17 | LAVA Therapeutics NV (LVTX) Delisted | Disp (D) | −10,000 | $0 | EDGAR |
| 2025-11-10 | SER | Grant (A) | — | $0 | EDGAR |
| 2025-05-20 | ELTX | Grant (A) | — | $0 | EDGAR |
| 2025-02-18 | LAVA Therapeutics NV (LVTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-01-15 | SER | Grant (A) | — | $0 | EDGAR |
| 2024-11-25 | ELTX | Grant (A) | — | $0 | EDGAR |
| 2023-12-29 | ELTX | Grant (A) | — | $0 | EDGAR |
| 2022-06-13 | Elicio Therapeutics, Inc. (ANGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-17 | Vaxart, Inc. (VXRT) Delisted | Grant (A) | — | $0 | EDGAR |